SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,154,605 | -23.1% | 1,197,152 | +3.1% | 0.00% | -100.0% |
Q2 2023 | $5,401,123 | +10.7% | 1,161,532 | +10.0% | 0.00% | 0.0% |
Q1 2023 | $4,880,170 | +59053.6% | 1,056,314 | +3.5% | 0.00% | 0.0% |
Q4 2022 | $8,250 | -99.8% | 1,021,079 | +20.0% | 0.00% | 0.0% |
Q3 2022 | $4,721,000 | +11.2% | 850,747 | +4.4% | 0.00% | 0.0% |
Q2 2022 | $4,245,000 | -34.5% | 814,789 | +3.3% | 0.00% | 0.0% |
Q1 2022 | $6,483,000 | -41.4% | 788,796 | +6.1% | 0.00% | 0.0% |
Q4 2021 | $11,065,000 | -15.3% | 743,679 | +7.5% | 0.00% | -50.0% |
Q3 2021 | $13,071,000 | +3.8% | 691,976 | +2.1% | 0.00% | 0.0% |
Q2 2021 | $12,598,000 | -2.3% | 677,706 | +19.6% | 0.00% | 0.0% |
Q1 2021 | $12,896,000 | +41.9% | 566,649 | +35.4% | 0.00% | 0.0% |
Q4 2020 | $9,085,000 | +182.1% | 418,519 | +30.6% | 0.00% | +100.0% |
Q3 2020 | $3,220,000 | +58.2% | 320,484 | +22.2% | 0.00% | – |
Q2 2020 | $2,035,000 | +67.1% | 262,322 | +119.6% | 0.00% | – |
Q1 2020 | $1,218,000 | -42.4% | 119,453 | -37.9% | 0.00% | – |
Q4 2019 | $2,116,000 | +152.2% | 192,432 | +108.3% | 0.00% | – |
Q3 2019 | $839,000 | -19.6% | 92,375 | +0.6% | 0.00% | – |
Q2 2019 | $1,044,000 | +71.1% | 91,793 | +71.2% | 0.00% | – |
Q1 2019 | $610,000 | -33.1% | 53,620 | -47.0% | 0.00% | – |
Q4 2018 | $912,000 | – | 101,202 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |